Atrium completes the sale of its Active Ingredients and Specialty Chemicals division
Advertisement
In accordance with the terms previously announced, Atrium Innovations Inc. announced that it has completed the sale of its Active Ingredients and Specialty chemicals division for total proceeds of US$166.4 million in cash, subject to a post-closing working capital adjustment. Atrium is now a health and nutrition pure-play and the net proceeds from the transaction shall provide the Company with better financial flexibility to pursue its corporate strategy.